CLLD6 anticorps (Cy5)

N° du produit ABIN1421508

Détail du produit anti-CLLD6 anticorps (Cy5)

Antigène: CLLD6 (C13orf1) (Chromosome 13 Open Reading Frame 1 (C13orf1))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CLLD6 est conjugé à/à la Cy5

Application: Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Réactivité croisée: Humain, Souris, Rat

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human CLLD6/C13orf1

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur CLLD6

Antigène: CLLD6 (C13orf1) (Chromosome 13 Open Reading Frame 1 (C13orf1))

Autre désignation: CLLD6 (C13orf1 Produits)

Synonymes: anticorps C13orf1, anticorps CLLD6, anticorps fd05e05, anticorps MGC56247, anticorps zgc:56247, anticorps wu:fd05e05, anticorps si:dz79f24.1, anticorps dZ79F24.1-001, anticorps si:busm1-79f24.1, anticorps C1H13orf1, anticorps c13orf1, anticorps Clld6, anticorps RGD1306437, anticorps 6330409N04Rik, anticorps C12H13orf1, anticorps zgc:66415, anticorps zgc:77103, anticorps SPRY domain containing 7, anticorps SPRY domain containing 7a, anticorps SPRY domain containing 7 S homeolog, anticorps SPRY domain containing 7b, anticorps SPRYD7, anticorps spryd7a, anticorps spryd7.S, anticorps spryd7, anticorps Spryd7, anticorps spryd7b

Sujet:

Synonyms: Chromosome 13 open reading frame 1, Chronic lymphocytic leukemia deletion region gene 6 protein, CLL deletion region gene 6 protein, CLLD 6, CLLD6, Hypothetical protein LOC57213, SPRY7_HUMAN.

Background: CLLD6, is a 196 amino acid protein that contains one B30.2/SPRY domain. Expression of CLLD6 is found at highest levels in heart, skeletal muscle and testis, with lower levels found in thymus, peripheral blood leukocytes, lymph node and bone marrow. Existing as two alternatively spliced isoforms, CLLD6 maps to human chromosome 13, which comprises nearly 4 % of human DNA and contains about 114 million base pairs and 400 genes. Key tumor suppressor genes on chromosome 13 include the breast cancer susceptibility gene, BRCA2, and the RB1 (retinoblastoma) gene. RB1 encodes a crucial tumor suppressor protein which, when defective, leads to malignant growth in the retina and has been implicated in a variety of other cancers. The gene SLITRK1, which is associated with Tourette syndrome, is on chromosome 13. As with most chromosomes, polysomy of part or all of chromosome 13 is deleterious to development and decreases the odds of survival.